These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34572393)

  • 1. Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease.
    Flores-López M; García-Marchena N; Pavon FJ; Lara E; Porras-Perales O; Araos P; Requena-Ocaña N; Torres-Galván S; Mañas-Padilla MC; Rubio G; Suárez J; Santín LJ; Rodríguez de Fonseca F; Castilla-Ortega E; García-Fernández MI; Serrano A
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders.
    Flores-López M; García-Marchena N; Araos P; Requena-Ocaña N; Porras-Perales O; Torres-Galván S; Suarez J; Pizarro N; de la Torre R; Rubio G; Ruiz-Ruiz JJ; Rodríguez de Fonseca F; Serrano A; Pavón-Morón FJ
    Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.
    She S; Zhang Q; Shi J; Yang F; Dai K
    Front Oncol; 2022; 12():922945. PubMed ID: 35769713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.
    Kaffe E; Magkrioti C; Aidinis V
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toluene diisocyanate: Induction of the autotaxin-lysophosphatidic acid axis and its association with airways symptoms.
    Broström JM; Ye ZW; Axmon A; Littorin M; Tinnerberg H; Lindh CH; Zheng H; Ghalali A; Stenius U; Jönsson BA; Högberg J
    Toxicol Appl Pharmacol; 2015 Sep; 287(3):222-31. PubMed ID: 26072274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.
    Dong YL; Duan XY; Liu YJ; Fan H; Xu M; Chen QY; Nan Z; Wu H; Deng SJ
    Inflammation; 2019 Oct; 42(5):1530-1541. PubMed ID: 31102124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes.
    Honjo M; Igarashi N; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Weinreb RN; Aihara M
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):693-701. PubMed ID: 29392315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
    Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.
    Baader M; Bretschneider T; Broermann A; Rippmann JF; Stierstorfer B; Kuttruff CA; Mark M
    Br J Pharmacol; 2018 Feb; 175(4):693-707. PubMed ID: 29197066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis.
    Booijink R; Salgado-Polo F; Jamieson C; Perrakis A; Bansal R
    EMBO Mol Med; 2022 Sep; 14(9):e16333. PubMed ID: 35833384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients.
    García-Marchena N; Pizarro N; Pavón FJ; Martínez-Huélamo M; Flores-López M; Requena-Ocaña N; Araos P; Silva-Peña D; Suárez J; Santín LJ; de la Torre R; Rodríguez de Fonseca F; Serrano A
    Sci Rep; 2020 Oct; 10(1):17163. PubMed ID: 33051508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotaxin and chronic inflammatory diseases.
    Magkrioti C; Galaris A; Kanellopoulou P; Stylianaki EA; Kaffe E; Aidinis V
    J Autoimmun; 2019 Nov; 104():102327. PubMed ID: 31471142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.
    Pleli T; Martin D; Kronenberger B; Brunner F; Köberle V; Grammatikos G; Farnik H; Martinez Y; Finkelmeier F; Labocha S; Ferreirós N; Zeuzem S; Piiper A; Waidmann O
    PLoS One; 2014; 9(7):e103532. PubMed ID: 25062038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.
    Farquhar MJ; Humphreys IS; Rudge SA; Wilson GK; Bhattacharya B; Ciaccia M; Hu K; Zhang Q; Mailly L; Reynolds GM; Ashcroft M; Balfe P; Baumert TF; Roessler S; Wakelam MJO; McKeating JA
    J Hepatol; 2017 May; 66(5):919-929. PubMed ID: 28126468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotaxin in Pathophysiology and Pulmonary Fibrosis.
    Ninou I; Magkrioti C; Aidinis V
    Front Med (Lausanne); 2018; 5():180. PubMed ID: 29951481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin in liver fibrosis.
    Ikeda H; Yatomi Y
    Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.